慢性丙型肝炎的治疗效果研究

• 作 者: C.Niederau T.Heintges M.Wenning A.Erhard W.Petry 郝连杰
• 机 构: Medizinische,Medizinische,Medizinische,Medizinische,Medizinische,同济医科大学附属同济医院 Klinik und Poliklinik,
• 出 处: The Chinese-German Journal of Clinical Oncology
• 发表日期: 1997年03期
• 关键词: 慢性丙型肝炎 干扰素治疗 自然史 抗体检测 透析病人 自身免疫性肝炎 肝脏组织学 血液制品 抗病毒药物 肝活检

丙型肝炎的自然史 1989年确定的丙型肝炎病毒(HCV)是过去称谓非甲非乙型慢性肝炎90％病因,感染可通过输血、血液制品肠道外传播,因此可在一定的风险组检出(例如:血友病、透析病人、药瘾者等),但是仍有40％～50％病人的传播途径不明。用特异性和敏感的第二代或第三代HCV-抗体检测试剂可在德国人群中0.5％～0.8％检出具有针对HCV的抗体,其

The Natural History of Hepatitis C The 1989 hepatitis C virus (HCV) was defined as the past etiology of non-A, non-B, chronic hepatitis 90% of the causes of which infection can be transmitted through blood transfusions, blood products parenteral and can therefore be screened at a certain risk (For example: hemophilia, dialysis patients, drug addicts, etc.), but 40% to 50% of patients still have an unknown route of transmission. Antibodies against HCV can be detected in 0.5% to 0.8% of the German population using specific and sensitive second- or third-generation HCV-antibody detection reagents